The US may make anti-overdose drug naloxone available over the counter in 2024ByAnnalisa MerelliPublishedDecember 27, 2022
The end of zero-covid pushed China's biggest funeral services stock up by 80%ByAnnalisa MerelliPublishedDecember 27, 2022
The US is about to make opioid addiction treatment much easierByAnnalisa MerelliPublishedDecember 21, 2022
Health insurance rates will rise faster in 2023 in these US statesByAnnalisa MerelliUpdatedDecember 19, 2022
The return of free at-home covid tests for US households is a quiet message from the White HouseByAnnalisa MerelliPublishedDecember 17, 2022
New Zealand's new cigarette law is fighting the wrong warByAnnalisa MerelliPublishedDecember 15, 2022
The 8 countries that wanted Iran to stay on the UN's Commission on the Status of WomenByAnnalisa MerelliPublishedDecember 14, 2022
How AbbVie denied Americans access to fair competition for HumiraByAnnalisa MerelliPublishedDecember 14, 2022
10 best practices for equitable global health journalismByMadhukar Pai and Annalisa MerelliPublishedDecember 7, 2022
CVS was sued for using customer donations at checkout to fund a corporate philanthropy pledgeByAnnalisa MerelliPublishedDecember 6, 2022
NYC's new plan to forcibly hospitalize homeless people is a waste of taxpayer moneyByAnnalisa MerelliPublishedDecember 3, 2022
How to remove Iran from the UN Commission on the Status of WomenByAnnalisa MerelliPublishedNovember 30, 2022
In Colombia, women’s health paid the price of misguided drug control policiesByAnnalisa MerelliPublishedNovember 23, 2022
The world’s population just hit 8 billion—and that's okayBySamanth Subramanian, Annalisa Merelli, and Amanda ShendrukPublishedNovember 15, 2022
The 6 states where abortion is on the ballot in the 2022 midterm electionsByAnnalisa MerelliPublishedNovember 8, 2022
The companies responsible for the $1.5 trillion-a-year US opioid crisis will pay a total of $53 billion for itByAnnalisa MerelliPublishedNovember 2, 2022
